Allogene Therapeutics, Inc.
ALLO
$2.22
$0.073.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 250.21M | 252.19M | 273.12M | 280.04M | 292.48M |
| Total Receivables | 1.50M | 2.10M | 1.70M | 2.30M | 1.90M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.04M | 6.43M | 7.84M | 9.23M | 9.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 257.75M | 260.72M | 282.66M | 291.58M | 303.39M |
|
|
|||||
| Total Current Assets | 257.75M | 260.72M | 282.66M | 291.58M | 303.39M |
| Net Property, Plant & Equipment | 112.73M | 116.83M | 120.82M | 127.07M | 131.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 37.39M | 37.28M | 37.60M | 33.83M | 33.39M |
| Total Assets | 415.91M | 439.77M | 470.59M | 507.98M | 548.71M |
|
|
|||||
| Total Accounts Payable | 4.27M | 3.70M | 4.85M | 5.06M | 5.39M |
| Total Accrued Expenses | 17.64M | 20.13M | 19.07M | 17.33M | 21.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.21M | 8.01M | 7.76M | 7.63M | 7.51M |
| Total Finance Division Other Current Liabilities | 2.40M | -- | -- | -- | 1.07M |
| Total Other Current Liabilities | 2.40M | -- | -- | -- | 1.07M |
| Total Current Liabilities | 32.51M | 31.83M | 31.68M | 30.02M | 35.52M |
|
|
|||||
| Total Current Liabilities | 32.51M | 31.83M | 31.68M | 30.02M | 35.52M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 75.05M | 77.13M | 79.24M | 81.29M | 83.25M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.80M | 15.48M | 15.12M | 11.28M | 7.76M |
| Total Liabilities | 123.36M | 124.44M | 126.03M | 122.59M | 126.53M |
|
|
|||||
| Common Stock & APIC | 2.30B | 2.29B | 2.28B | 2.26B | 2.24B |
| Retained Earnings | -2.01B | -1.97B | -1.93B | -1.88B | -1.82B |
| Treasury Stock & Other | 269.00K | 235.00K | -45.00K | 43.00K | -89.00K |
| Total Common Equity | 292.54M | 315.33M | 344.56M | 385.39M | 422.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 292.54M | 315.33M | 344.56M | 385.39M | 422.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 292.54M | 315.33M | 344.56M | 385.39M | 422.18M |
|
|
|||||